v3.26.1
Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2026
Stock-Based Compensation [Abstract]  
Schedule of Weighted-Average Grant Date Fair Value of Options Granted The following assumptions were used in the fair-value method calculations:
      Year Ended March 31,  
      2026       2025  
Risk-free interest rates     3.63% – 4.14%       3.45% – 4.49%  
Volatility     102% – 108%       107% – 123%  
Expected life (years)     5.0 – 5.7       5.0 – 5.7  
Dividend yield            
Schedule of Shares Available for Grant Under the Plan

The following table summarizes the activity in the shares available for grant under the Plan during the years ended March 31, 2026 and 2025:

 

          Options Outstanding  
    Shares Available for Grant     Number of Shares     Weighted Average Exercise Price ($)  
Balance at March 31, 2024     121,620       122,977       111.00  
Additional shares authorized under the Plan     100,000              
Options granted     (52,661 )     52,661       46.50  
Options exercised           (251 )     32.40  
Share awards     (516 )            
Options cancelled and returned to the Plan     11,485       (11,485 )     46.50  
Balance at March 31, 2025     179,928       163,902       95.10  
Additional shares authorized under the Plan     100,000              
Options granted     (215,364 )     215,364       14.74  
Reverse stock split adjustment           480        
Share awards     (853 )            
Options cancelled and returned to the Plan     53,651       (53,651 )     32.70  
Balance at March 31, 2026     117,362       326,095       51.97  
Schedule of RSU Activity under the Plan

A summary of RSU activity under the Plan is presented below.

 

          Weighted  
          Average  
          Grant-Date  
    Number of     Fair Value  
    Shares     ($)  
Balance at March 31, 2024     6,250       0.91  
Vested     (2,778 )     0.91  
Balance at March 31, 2025     3,472       0.91  
Vested     (2,777 )     0.91  
Balance at March 31, 2026     695       0.91  
Schedule of Outstanding and Exercisable Options

The following table summarizes the range of outstanding and exercisable options as of March 31, 2026:

 

    Options Outstanding     Options Exercisable  
Range of Exercise Price   Number
Outstanding
    Weighted
Average
Remaining
Contractual
Life
(in Years)
    Weighted
Average
Exercise
Price
($)
    Number
Exercisable
    Weighted
Average
Exercise
Price
($)
    Aggregate
Intrinsic
Value
($)
 
$5.40 – $68.40     279,520       8.71       24.88       149,897       37.04       958  
$118.50 – $225.30     30,471       5.17       159.82       30,471       159.82        
$258.30 – $531.00     16,104       5.23       317.72       16,104       317.72        
$5.40 – $531.00     326,095       8.21       51.97       196,472       74.08       958